Collaborator Profiles - Calico
Skip to content
0%
Calico
Research & Technology
Research & Technology
Publications
Drug Development
Drug Development
Patients
Partnering
Leadership
Careers
Job Openings
PostDoc Program
Mission and Values
Leadership
Research & Technology
Drug Development
Patients
Partnering
Collaborator Profiles
People
Publications
News & Media
Press Releases
Calico Stories
Life at Calico
Careers
Job Openings
PostDoc Program
Contact Us
Collaborator Profiles
We collaborate with leading research institutions and biotechnology companies to boldly follow our mission. Together, we are expanding our understanding of the biology that controls human aging and devising interventions that enable people to lead longer and healthier lives. 
Some of our collaborators include:
Since 2014, the collaboration between Calico and AbbVie has produced a number of drug development programs, with multiple assets advanced into clinical trials, including potential treatments for neurological conditions. Calico is now independently moving these clinical programs forward.
Since 2015, Calico and the Broad Institute of MIT and Harvard have partnered to investigate the biology and genetics of aging and pursue early-stage drug discovery. Through our collaborative work, we have made progress across a number of programs including the co-development of a novel PTPN2/N1 inhibitor now in clinical trials.
Learn more about our collaboration with the Broad Institute:
Calico and Broad Institute Extend Collaboration Adding Focus on Age-Related Neurodegeneration
Translational Science Thrives in the Calico-Broad Collaboration
Established in 2018, Calico’s partnership with UK Biobank has focused on the progression of major chronic diseases of mid-to-later life and enabling researchers to explore the mechanisms through which these diseases occur in people. Through a joint project between Calico, the UK Biobank, and the Chan Zuckerberg Initiative, we are analyzing tens of thousands of MRI scans and genetic data to create the world’s largest longitudinal imaging dataset to assess disease progression. All findings from his collaboration will be publicly available to support global scientific progress.
Learn more about our collaboration with the UK Biobank:
Public-private partnership announces ambitious project to create the world’s largest longitudinal imaging dataset to assess disease progression
Uncovering New Signs of Aging in Blood
Investigating Aging in Humans at Population Scale
We welcome proposals for partnership. If you would like to collaborate with Calico, please provide us with a brief non-confidential proposal that describes the opportunity, including scientific supporting data, to busdev@calicolabs.com.
About Us
Research & Technology
Drug Development
Leadership
Partnering
Our Story
Life at Calico
Resources
Publications
Calico Stories
News & Media
Patients
Contact Us
Contact Us
Join Us
Follow Us
X
LinkedIn
Privacy Policy
Notice at Collection
Terms of Use
Code of Conduct
2026 Calico Life Sciences LLC. All rights reserved.
Close